Specifically, we uncover cancer vulnerabilities amongst synthetic lethal hits with EXO1 loss, including deficiencies in BRCA1-A complex factors, FA pathway genes and the splicing factor and tumour suppressor ZRSR2. Here, EXO1 is linked to cancer.